| abstract |
This invention relates to the use of compounds of formula (I) wherein R<1>, R<2>, R<3>, R<4> and R<5> are as defined in the description, A signifies -CH=CH- or -C=C-; and B signifies (B1); (B2); (B3); (B4); (B5) or (B6); wherein R<6> to R<26>, X and Y have the significances given in the description, as well as pharmaceutically acceptable salts thereof, for the manufacture of medicaments for the treatment or prevention of mGluR5 receptor mediated disorders. |